SCI Ventures — Pre-Seed & Seed VC Firm
SCI Ventures is a Pre-Seed, Seed, Series A venture capital firm investing in Healthcare, AI / ML, SaaS. The firm has 10 portfolio companies in our records.
- Portfolio
- 10 companies on record
- Partners
- 6 listed
- Stage
- Pre-Seed, Seed, Series A
- Sectors
- Healthcare, AI / ML, SaaS
- Check size
- Not in our records
- AUM
- Not in our records
Last verified: 2026-10-28
Pre-Seed, Seed, Series A
10+ companies
6 partners
Investment Thesis
A specialist venture philanthropy fund dedicated to paralysis, neuro-restoration, and cure-oriented therapies. It backs early-stage technologies and treatments that restore function for people living with spinal cord injury and related neurologic impairment.
How SCI Ventures invests
SCI Ventures is a vc firm. The firm invests at the Pre-Seed, Seed, Series A stages, with a focus on Healthcare, AI / ML, SaaS.
SCI Ventures has backed 10 companies in our records, including ViaNautis, NervGen Pharma, Axonis.
Partners & Team
Roman Rothaermel, PhD
Investment Principal
Biotech Operator, PhD Neuroscience University of Oxford
Not disclosed
GP
Tom Londres
Board Member
Board Member, Reeve Foundation CEO, Metro Commercial, Inc.
Ian Curtis
Board Member
Board Member, ISRT and Reeve Foundation Chairman, HPC plc, Former PwC Partner
Adrien Cohen
Founding Managing Director, Board & Investment Committee Member
Industry Focus
Invests In
Portfolio Companies (10)
Other
ViaNautis
Targeted delivery of regenerative cargo to the brain and specific tissues has been a major challenge in central nervous-system repair.
NervGen Pharma
NervGen Pharma (NASDAQ: NGEN) is developing drug treatments that allow the central nervous system to regenerate itself.
Axonis
Axonis Therapeutics is developing medicines for neuron restoration and neuromodulation.
Cyllene Therapeutics
Cyllene Therapeutics (formerly: EG 427) has developed a platform technology to create targeted gene therapies tailored to specific neuronal populations.
Healx
Healx is one of the few AI-based discovery companies that have successfully shown the power of their approach across multiple indications.
Precision Neuroscience
Precision Neuroscience was founded to create the next generation of brain-computer interfaces to restore interaction with the environment.
Sania Therapeutics
Sania has developed a gene-therapy platform to selectively target dysfunctional neural circuits.
Onward Medical
Onward is the leader in the spinal cord stimulation space, focusing on targeted, programmed stimulation of the spinal cord.
Augmental
Augmental has developed the MouthPad: an in-mouth interface for hands-free human-computer interaction.
Axonis Therapeutics
Developing medicines for neuron restoration and neuromodulation.
- •Raising at Pre-Seed, Seed, Series A? You're squarely in their sweet spot.
- •Lead with your fit in Healthcare, AI / ML, SaaS — the sectors they actively back.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Roman Rothaermel, PhD, Investment Principal.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if SCI Ventures is a match for your startup
Upload your pitch deck to see how well you match with SCI Ventures and 10,000+ other investors.
Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT
Is this your profile? Request a correction or removal